Keyword: Merkel cell carcinoma (MCC)

News

Merck-Pfizer Avelumab on FDA Fast Track

08.10.2015 - After previously receiving Orphan Drug status for avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody to treat the rare and aggressive skin cancer Merkel...

News

Merck and Pfizer Get FDA Orphan Drug Status

30.09.2015 - An alliance of Germany’s Merck KGaA and US pharmaceuticals giant Pfizer has been granted US Food and Drug Administration (FDA) orphan drug status for its investigational cancer...